Profit

Pakistan consumer sector profit rises 28% to Rs244 billion in 2025

Pharma profits jump 79% to Rs36 billion, discretionary earnings reach Rs98 billion, staples at Rs110 billion on revenue growth and stable exchange rate

Monitoring Report

Monitoring Report

April 15, 2026

1 min read
Pakistan consumer sector profit rises 28% to Rs244 billion in 2025

Listed consumer sector companies in Pakistan posted a combined profit of Rs244 billion in 2025, marking a 28% increase compared to the previous year, according to an analysis by Topline Securities.

The study covered consumer staples, pharmaceuticals and discretionary firms with market capitalisation exceeding $100 million in their respective segments.

Net revenues for these companies grew 14% year-on-year, supported by improved macroeconomic conditions and a relatively stable exchange rate.

Pharmaceutical companies recorded the highest growth, with profits rising 79% to Rs36 billion. The increase was attributed to improved gross margins, supported by lower global active pharmaceutical ingredient (API) costs and deregulation of non-essential drug prices.

Discretionary sector companies reported a 35% increase in profits to Rs98 billion. Gross margins in this segment improved to 17.32% in 2025 from 15% in 2024, driven by stable currency conditions, higher automobile sales and the introduction of new product variants.

Consumer staples companies posted profits of Rs110 billion, reflecting a 13% increase over the previous year.

Analysts said the overall growth in the consumer sector reflects improving demand conditions and cost dynamics across key segments.

Share:
Monitoring Report
Monitoring Report

Our monitoring team diligently searches the vast expanse of the web to carefully handpick and distill top-tier business and economic news stories and articles, presenting them to you in a concise and informative manner.

View all articles →

Comments

Supports: **bold** *italic* [link](url) > quote @mention0/2000
Guest comments require moderation

No comments yet. Be the first to join the discussion!